MedPath

Travoprost

These highlights do not include all the information needed to use TRAVOPROST OPHTHALMIC SOLUTION (Ionic Buffered Solution) safely and effectively. See full prescribing information for TRAVOPROST OPHTHALMIC SOLUTION (Ionic Buffered Solution).

Approved
Approval ID

98fb77b8-ee41-e2fc-7bcd-bc350e19cc10

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 22, 2025

Manufacturers
FDA

Apotex Corp.

DUNS: 845263701

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

travoprost

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60505-0593
Application NumberANDA203431
Product Classification
M
Marketing Category
C73584
G
Generic Name
travoprost
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateSeptember 22, 2025
FDA Product Classification

INGREDIENTS (9)

TRAVOPROSTActive
Quantity: 0.04 mg in 1 mL
Code: WJ68R08KX9
Classification: ACTIB
PEG-40 CASTOR OILInactive
Code: 4ERD2076EF
Classification: IACT
BORIC ACIDInactive
Code: R57ZHV85D4
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
ZINC CHLORIDEInactive
Code: 86Q357L16B
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 10/1/2024

CARTON LABEL - PRINCIPAL DISPLAY PANEL - 2.5 mL

APOTEX CORP. NDC 60505-0593-4

Travoprost Ophthalmic Solution, USP (Ionic Buffered Solution) 0.004%

Equivalent to 0.04 mg travoprost

Rx Only

carton

DESCRIPTION SECTION

LOINC: 34089-3Updated: 5/29/2020

11 DESCRIPTION

Travoprost is a synthetic prostaglandin F analogue. Its chemical name is [1R-[1α(Z),2β(1E,3R*),3α,5α]]-7-[3,5-Dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl) phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic acid, 1-methylethylester. It has a molecular formula of C26H35F3O6 and a molecular weight of 500.55 g/mol. The chemical structure of travoprost is:

chemical

Travoprost is a clear, colorless to slightly yellow oil that is very soluble in acetonitrile, methanol, octanol, and chloroform. It is practically insoluble in water.

Travoprost ophthalmic solution, USP (ionic buffered solution) 0.004% is supplied as sterile, buffered aqueous solution of travoprost with a pH of approximately 5.7 and an osmolality of approximately 290 mOsmol/kg.

Travoprost ophthalmic solution, USP (ionic buffered solution) contains Active: travoprost 0.04 mg/mL;Inactives: polyoxyl 40 hydrogenated castor oil, ionic buffered system (boric acid, propylene glycol, sorbitol, zinc chloride), sodium hydroxide and/or hydrochloric acid (to adjust pH), and water for injection. Preserved in the bottle with an ionic buffered system.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Travoprost - FDA Drug Approval Details